Open AccessErratum for Kamal et al., A Drug-Disease Model Describing the Effect of Oseltamivir Neuraminidase Inhibition on Influenza Virus Progression
Author(s) -
Mohamed Kamal,
Ronald Gieschke,
Annabelle LemenuelDiot,
Catherine A. A. Beauchemin,
Patrick F. Smith,
Craig R. Rayner
Publication year - 2016
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.00179-16
Subject(s) - oseltamivir , neuraminidase , neuraminidase inhibitor , virology , drug , virus , microbiology and biotechnology , medicine , pharmacology , disease , biology , infectious disease (medical specialty) , covid-19
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom